At a glance
- Originator Aurobindo Pharma
- Class 3-ring heterocyclic compounds; Antiretrovirals; Azepines; Cyclopropanes; Pyridines; Small molecules
- Mechanism of Action Non-nucleoside reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed HIV-1 infections
Most Recent Events
- 23 Nov 2018 Launched for HIV-1 infections in USA prior November 2018 (Aurobindo Pharma website, November 2018) (PO)